Harald Hampel

95.4k total citations · 15 hit papers
496 papers, 35.3k citations indexed

About

Harald Hampel is a scholar working on Physiology, Psychiatry and Mental health and Cognitive Neuroscience. According to data from OpenAlex, Harald Hampel has authored 496 papers receiving a total of 35.3k indexed citations (citations by other indexed papers that have themselves been cited), including 272 papers in Physiology, 237 papers in Psychiatry and Mental health and 119 papers in Cognitive Neuroscience. Recurrent topics in Harald Hampel's work include Alzheimer's disease research and treatments (266 papers), Dementia and Cognitive Impairment Research (216 papers) and Functional Brain Connectivity Studies (98 papers). Harald Hampel is often cited by papers focused on Alzheimer's disease research and treatments (266 papers), Dementia and Cognitive Impairment Research (216 papers) and Functional Brain Connectivity Studies (98 papers). Harald Hampel collaborates with scholars based in Germany, United States and France. Harald Hampel's co-authors include Kaj Blennow, Stefan Teipel, Henrik Zetterberg, Arun L.W. Bokde, Simone Lista, Michael W. Weiner, Michael Ewers, Andrea Vergallo, Katharina Büerger and Bruno Dubois and has published in prestigious journals such as Journal of Biological Chemistry, Neuron and Journal of Neuroscience.

In The Last Decade

Harald Hampel

484 papers receiving 34.6k citations

Hit Papers

Cerebrospinal fluid and plasma biomarkers in Alzheimer di... 2003 2026 2010 2018 2010 2018 2016 2021 2003 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
    2010 1.4k citations Kaj Blennow, Harald Hampel et al. Nature Reviews Neurology profile →
  2. The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
    2018 1.2k citations Harald Hampel, Ezio Giacobini et al. profile →
  3. A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
    2016 1.2k citations Clifford R. Jack, Kaj Blennow et al. profile →
  4. The Amyloid-β Pathway in Alzheimer’s Disease
    2021 1.1k citations Harald Hampel, John Hardy et al. Molecular Psychiatry profile →
  5. CSF markers for incipient Alzheimer's disease
    2003 977 citations Kaj Blennow, Harald Hampel profile →
  6. Sex differences in Alzheimer disease — the gateway to precision medicine
    2018 613 citations Maria Teresa Ferretti, M. Florencia Iulita et al. Nature Reviews Neurology profile →
  7. Classifying brain states and determining the discriminating activation patterns: Support Vector Machine on functional MRI data
    2005 540 citations Arun L.W. Bokde, Harald Hampel et al. profile →
  8. Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives
    2010 469 citations Harald Hampel, Stefan Teipel et al. profile →
  9. Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic
    2018 464 citations Harald Hampel, Colin L. Masters et al. Nature Reviews Neurology profile →
  10. Current state of Alzheimer’s fluid biomarkers
    2018 375 citations Richard Batrla, Jeffrey L. Cummings et al. profile →
  11. Implementation of subjective cognitive decline criteria in research studies
    2016 375 citations Bruno Dubois, Harald Hampel et al. Alzheimer s & Dementia profile →
  12. Exercise benefits on Alzheimer’s disease: State-of-the-science
    2020 228 citations Pedro L. Valenzuela, Harald Hampel et al. Ageing Research Reviews profile →
  13. Developing the ATX(N) classification for use across the Alzheimer disease continuum
    2021 205 citations Harald Hampel, Jeffrey L. Cummings et al. Nature Reviews Neurology profile →
  14. Amyloid-related imaging abnormalities (ARIA): radiological, biological and clinical characteristics
    2023 159 citations Harald Hampel, Min Cho et al. profile →
  15. Blood-based biomarkers for Alzheimer’s disease: Current state and future use in a transformed global healthcare landscape
    2023 121 citations Harald Hampel, Yan Hu et al. profile →

Peers

Harald Hampel
Comparison fields: 5 of 190
  • Physiology 17.8k
  • Psychiatry and Mental health 13.9k
  • Cognitive Neuroscience 7.8k
  • Molecular Biology 7.6k
  • Neurology 6.0k
Replace Hilkka Soininen with:
Hilkka Soininen Finland
Chester A. Mathis United States
William E. Klunk United States
Bruno Dubois France
Leslie M. Shaw United States
Eric M. Reiman United States
Richard Mayeux United States
Reisa A. Sperling United States
Paul Aisen United States
Victor L. Villemagne Australia
Hilkka Soininen Finland View profile →
Citations per field, relative to Harald Hampel
Harald Hampel · 1×
Citations per year, relative to Harald Hampel
Harald Hampel · 1×

Countries citing papers authored by Harald Hampel

Since Specialization
Citations

This map shows the geographic impact of Harald Hampel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harald Hampel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harald Hampel more than expected).

Fields of papers citing papers by Harald Hampel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harald Hampel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harald Hampel. The network helps show where Harald Hampel may publish in the future.

Co-authorship network of co-authors of Harald Hampel

This figure shows the co-authorship network connecting the top 25 collaborators of Harald Hampel. A scholar is included among the top collaborators of Harald Hampel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harald Hampel. Harald Hampel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1
Advancing Early Detection of Alzheimer Disease in the Primary Care Setting in the United States
2025 ·Neurology Clinical Practice ·Michelle M. Mielke, (unknown), Yan Hu, Min Cho, Jonathan Liss, Jeffrey M. Burns, Thomas O. Obisesan, (unknown), (unknown), Steven R. Smith, (unknown), Monica W. Parker, (unknown), Harald Hampel
0
2
Amyloid-related imaging abnormalities (ARIA) and their radiological, biological and clinical characteristics: a plain language summary
2024 ·Neurodegenerative Disease Management ·Harald Hampel, (unknown), Min Cho, James A. R. Nicoll, Alireza Atri
3
3
Advancing Early Detection of Alzheimer’s Disease in the Primary Care Setting in the United States
2024 ·Alzheimer s & Dementia ·Michelle M. Mielke, (unknown), Yan Hu, Min Cho, Jonathan Liss, Jeffrey M. Burns, Thomas O. Obisesan, (unknown), (unknown), Steven R. Smith, (unknown), Monica W. Parker, J. Simon Bell, Harald Hampel
0
4
Plasma pTau217 predicts continuous brain amyloid levels in preclinical and early Alzheimer's disease
2024 ·Alzheimer s & Dementia ·Viswanath Devanarayan, T. Doherty, Arnaud Charil, Perminder S. Sachdev, Yuanqing Ye, (unknown), Daniel A. Llano, (unknown), Larisa Reyderman, Harald Hampel, Lynn D. Kramer, Shobha Dhadda, Michael C. Irizarry
21
5
Plasma pTau181 enhances the prediction of future clinical decline in amyloid‐positive mild cognitive impairment
2024 ·Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring ·Viswanath Devanarayan, Daniel A. Llano, Yan Hu, Harald Hampel, Lynn D. Kramer, Shobha Dhadda, Michael C. Irizarry
3
6
Alzheimer’s Disease and Neurosyphilis: Meaningful Commonalities and Differences of Clinical Phenotype and Pathophysiological Biomarkers
2023 ·Journal of Alzheimer s Disease ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Andrea Vergallo, Chiara Pizzanelli, Gloria Tognoni, Angelo Nuti, Roberto Ceravolo, Gabriele Siciliano, Harald Hampel, Filippo Baldacci
4
7
The age-specific comorbidity burden of mild cognitive impairment: a US claims database study
2023 ·Alzheimer s Research & Therapy ·Gang Li, Nicola Toschi, Viswanath Devanarayan, Richard Batrla, (unknown), Min Cho, (unknown), Feride Frech, James E. Galvin, David Henley, Soeren Mattke, Susan De Santi, Harald Hampel
11
8
Omics sciences for systems biology in Alzheimer’s disease: State-of-the-art of the evidence
2021 ·Ageing Research Reviews ·Harald Hampel, Robert Nisticò, Nicholas T. Seyfried, Allan I. Levey, Erica Modeste, Pablo Lemercier, Filippo Baldacci, Nicola Toschi, Francesco Garaci, George Perry, Enzo Emanuele, Pedro L. Valenzuela, Alejandro Lucía, Andrea Urbani, Giulia Maria Sancesario, Mark Mapstone, Massimo Corbo, Andrea Vergallo, Simone Lista
97
9
Developing the ATX(N) classification for use across the Alzheimer disease continuum breakdown →
2021 ·Nature Reviews Neurology ·Harald Hampel, Jeffrey L. Cummings, Kaj Blennow, Peng Gao, Clifford R. Jack, Andrea Vergallo
205
10
The Amyloid-beta Pathway in Alzheimer's Disease
2021 ·Molecular Psychiatry ·Harald Hampel, John Hardy, Kaj Blennow, Christopher Chen, George Perry, Seung Hyun Kim, Victor L. Villemagne, Paul Aisen, Michele Vendruscolo, Takeshi Iwatsubo, Colin L. Masters, Min Cho, Lars Lannfelt, Jeffrey L. Cummings, Andrea Vergallo
2
11
The Amyloid-β Pathway in Alzheimer’s Disease breakdown →
2021 ·Molecular Psychiatry ·Harald Hampel, John Hardy, Kaj Blennow, Christopher Chen, George Perry, Seung Hyun Kim, Victor L. Villemagne, Paul Aisen, Michele Vendruscolo, Takeshi Iwatsubo, Colin L. Masters, Min Cho, Lars Lannfelt, Jeffrey L. Cummings, Andrea Vergallo
1099
12
Sex differences in Alzheimer disease — the gateway to precision medicine breakdown →
2018 ·Nature Reviews Neurology ·(unknown), Maria Teresa Ferretti, M. Florencia Iulita, Enrica Cavedo, Patrizia A. Chiesa, Annemarie Schumacher Dimech, Antonella Santuccione Chadha, Francesca Baracchi, Hélène Girouard, Sabina Misoch, Ezio Giacobini, Herman Depypere, Harald Hampel
613
13
Low Cognitive Awareness, but Not Complaint, is a Good Marker of Preclinical Alzheimer's Disease.
2017 ·PubMed ·Federica Cacciamani, Caroline Tandetnik, Geoffroy Gagliardi, Hugo Bertin, Marie‐Odile Habert, Harald Hampel, Laurie Boukadida, (unknown), Stéphane Epelbaum, Bruno Dubois, (unknown)
45
14
The ε4 genotype of apolipoprotein E and white matter integrity in Alzheimer's disease
2013 ·Alzheimer s & Dementia ·(unknown), Peter Meyer, Carsten Holzmann, Martin Dyrba, Elisabeth Kasper, Arun L.W. Bokde, Andreas Fellgiebel, Thomas Meindl, Harald Hampel, Stefan Teipel, (unknown)
24
15
Grey matter correlates of clinical variables in amyotrophic lateral sclerosis (ALS): a neuroimaging study of ALS motor phenotype heterogeneity and cortical focality
2012 ·Journal of Neurology Neurosurgery & Psychiatry ·Peter Bede, Arun L.W. Bokde, Marwa Elamin, Susan Byrne, Russell L. McLaughlin, Norah Jordan, Harald Hampel, Laura Gallagher, Catherine Lynch, Andrew Fagan, Niall Pender, Orla Hardiman
117
16
Functional Connectivity Bias of the Orbitofrontal Cortex in Drug-Free Patients with Major Depression
2009 ·Biological Psychiatry ·Thomas Frodl, Arun L.W. Bokde, Johanna Scheuerecker, Danuta Lisiecka, Veronika Schoepf, Harald Hampel, Hans‐Jürgen Möller, H. Brückmann, Martin Wiesmann, Eva Meisenzahl
150
17
The pilot European Alzheimer's Disease Neuroimaging Initiative of the European Alzheimer's Disease Consortium
2008 ·Alzheimer s & Dementia ·Giovanni B. Frisoni, Wouter J.P. Henneman, Michael W. Weiner, Philip Scheltens, Bruno Vellas, Emma Reynish, (unknown), Harald Hampel, Katharina Bürger, Kaj Blennow, Gunhild Waldemar, Peter Johannsen, Lars‐Olof Wahlund, Giancarlo Zito, Paolo Maria Rossini, Bengt Winblad, Frederik Barkhof, (unknown)
36
18
Analytical performance and clinical utility of the INNOTEST® PHOSPHO-TAU(181P) assay for discrimination between Alzheimer's disease and dementia with Lewy bodies
2006 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·Hugo Vanderstichele, K De Vreese, Kaj Blennow, Niels Andreasen, Christian Sindic, Adrian Ivanoiu, Harald Hampel, Katharina Bürger, Lucilla Parnetti, Alessia Lanari, Alessandro Padovani, Mónica Di Luca, (unknown), Annika Olsson, Hans Pottel, Frank Hulstaert, Eugeen Vanmechelen
131
19
Assessment of various standards in a sandwich assay that detects tau phosphorylated at threonine 231 in cerebrospinal fluid
2001 ·The Society for Neuroscience Abstracts ·Raymond Zinkowski, Katharina Büerger, Daniel J. Kerkman, John F. DeBernardis, Christopher C.J. Miller, Harald Hampel, Peter Davies
1
20
[Multiconceptual therapy in Alzheimer's disease].
2000 ·PubMed ·(unknown), Katharina Bürger, Stéphane Schück, H.-J. Möller, С. И. Рапопорт, H. Allain, Harald Hampel
1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hilkka Soininen Breakdown of academic impact, for papers by Chester A. Mathis Breakdown of academic impact, for papers by William E. Klunk Breakdown of academic impact, for papers by Bruno Dubois Breakdown of academic impact, for papers by Leslie M. Shaw Breakdown of academic impact, for papers by Eric M. Reiman Breakdown of academic impact, for papers by Richard Mayeux Breakdown of academic impact, for papers by Reisa A. Sperling Breakdown of academic impact, for papers by Paul Aisen Breakdown of academic impact, for papers by Victor L. Villemagne
Rankless by CCL
2026